E. Anastassiades

Monitoring of iron requirements in renal patients on erythropoietin

E. Anastassiades, D. Howarth, J. Howarth et al. · Nephrology Dialysis Transplantation · 1993 · 50 citations

Quality of Life Improvements in Capd Patients Treated with Subcutaneously Administered Erythropoietin for Anemia

J Auer, Gail Simon, Judith M. Stevens et al. · Peritoneal Dialysis International · 1992 · 42 citations

Quality Of Life, Subcutaneously Administered Erythropoietin, Capd Patients Treated +20

Dialysis encephalopathy: precipitating factors and improvement in prognosis.

Platts Mm, E. Anastassiades · PubMed · 1981 · 36 citations

Hemodialysis, Urology, Renal Disease +15

The Anticoagulant Effect of Heparinoid Org 10172 During Haemodialysis: An Objective Assessment

Helen Ireland, David A. Lane, Angela Flynn et al. · Thrombosis and Haemostasis · 1986 · 32 citations

Objective Assessment, Dialysis Therapy, Heparinoid Org 10172 +21

A Low-Molecular-Weight Heparin (Kabi 2165, 'Fragmin') in Repeated Use for Haemodialysis: Prevention of Clotting and Prolongation of the Venous Compression Time in Comparison with Commercial Unfractionated Heparin

E. Anastassiades, H. Ireland, A. Flynn et al. · Nephrology Dialysis Transplantation · 1990 · 32 citations